Trials in Boston, Massachusetts
Here are the top 10 medical studies for prostate cancer in Boston, Massachusetts
Popular Filters
Phase 3 Trials
Hormone Therapy
AZD5305 for Prostate Cancer
Recruiting1 awardPhase 3
Providence, Rhode Island
This trial is testing a new drug called Saruparib combined with hormone treatment in adults with prostate cancer that has spread but still responds to hormones. The drug aims to stop cancer cells from repairing themselves, potentially slowing down the disease.
Radioisotope Therapy
177Lu-PSMA-617 + Standard Therapy for Prostate Cancer
Recruiting2 awardsPhase 3
Boston, Massachusetts
This trial tests if adding a radioactive drug to standard hormone treatments can better treat men with advanced prostate cancer. The drug targets and kills cancer cells with radiation, while standard treatments block hormones that help cancer grow.
Trials With No Placebo
Hormone Therapy
Androgen Receptor Antagonists for Prostate Cancer
Recruiting1 awardPhase < 1
Boston, Massachusetts
This trial will explore if hormonal therapies can increase PSMA levels in recurrent prostate cancer patients via PET/CT scans. 15 participants will receive androgen receptor antagonist monotherapy for 4 weeks.
Monoclonal Antibodies
PT217 for Small Cell Lung Cancer
Recruiting1 awardPhase 1 & 2
Boston, Massachusetts
This trial is testing a new antibody treatment called PT217 for patients with certain neuroendocrine cancers who haven't responded to usual treatments. PT217 helps the immune system target and destroy cancer cells by attaching to specific proteins on them.
Monoclonal Antibodies
REGN5678 +/- Cemiplimab for Prostate Cancer
Recruiting1 awardPhase 1 & 2
Boston, Massachusetts
This trial is testing a new drug, REGN5678, to see if it is safe and effective in treating prostate cancer. The study will also look at how well the drug is tolerated and how it works in the body.
Hormone Therapy
Abiraterone + Antiandrogen +/- Chemotherapy for Advanced Prostate Cancer
Recruiting1 awardPhase 2
Jonesboro, Arkansas
This trial is testing abiraterone acetate and antiandrogen therapy, with or without cabazitaxel and prednisone, to see how well it works in treating patients with castration-resistant prostate cancer that has spread to other parts of the body and has been previously treated with docetaxel.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.